Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 1,276 results for "Medical Malpractice Law & Strategy"...

Tort Reform Damage Caps in California, and Beyond
March 31, 2009
In last month's newsletter the authors looked at California's 25-year-old medical malpractice award damage cap legislation ' the Medical Injury Compensation Reform Act (MICRA) ' and began to explore arguments for and against its constitutionality. Herein, they continue that discussion.
State Claim Not Preempted By Federal Drug Labeling Law
March 31, 2009
The decisive March 4 U.S. Supreme Court ruling against Wyeth in a landmark pharmaceutical product liability case may also close off a major front in a hard-fought battle by businesses and the Bush administration to insulate national corporations from state tort litigation.
Medical-Legal Issues of Emergency Airway Management
March 31, 2009
The failure to manage a patient's airway can lead to lack of oxygenation and ventilation, and to resulting brain injury or death. Such failures can easily culminate in large awards. An expert explains.
Wyeth: The Plaintiff's Perspective
March 30, 2009
The authors claim that <i>Wyeth v. Levine</i> is a major victory for consumer advocates and champions of the civil justice system. Here's why.
<B>BREAKING NEWS:</B> Supreme Court's Wyeth Ruling Deals a Blow to Pre-emption Defense
March 05, 2009
The Supreme Court's decisive ruling on March 4 against Wyeth in a landmark pharmaceutical product liability case may also close off a major front in a hard-fought battle by businesses and the Bush administration to insulate national corporations from state tort litigation.
Verdicts
February 26, 2009
Recent important rulings of interest to your practice.
Verdicts
February 26, 2009
Recent important rulings of interest to your practice.
Drug & Device News
February 26, 2009
All the latest news you need to know.
Med Mal News
February 26, 2009
The latest news of interest to you and your practice.
Accessing Experimental Drugs Through the Compassionate Use Doctrine
February 26, 2009
In last month's issue, we discussed how Jacob Gunvalson, when denied entry into a clinical trial for a drug that might offer treatment for his terminal disease, sued the drug manufacturer to compel it to seek a "compassionate use" exemption. We conclude with a look at the litigation that ensued.

MOST POPULAR STORIES

  • Yachts, Jets, Horses & Hooch: Specialized Commercial Leasing Models
    Defining commercial real estate asset class is essentially a property explaining how it identifies — not necessarily what its original intention was or what others think it ought to be. This article discusses, from a general issue-spot and contextual analysis perspective, how lawyers ought to think about specialized leasing formats and the regulatory backdrops that may inform what the documentation needs to contain for compliance purposes.
    Read More ›
  • Identifying Your Practice's Differentiator
    How to Convey Your Merits In a Way That Earns Trust, Clients and Distinctions Just as no two individuals have the exact same face, no two lawyers practice in their respective fields or serve clients in the exact same way. Think of this as a "Unique Value Proposition." Internal consideration about what you uniquely bring to your clients, colleagues, firm and industry can provide untold benefits for your law practice.
    Read More ›
  • Risks and Ad Fraud Protection In Digital Advertising
    The ever-evolving digital marketing landscape, coupled with the industry-wide adoption of programmatic advertising, poses a significant threat to the effectiveness and integrity of digital advertising campaigns. This article explores various risks to digital advertising from pixel stuffing and ad stacking to domain spoofing and bots. It will also explore what should be done to ensure ad fraud protection and improve effectiveness.
    Read More ›